Ivan Pedrosa, M.D., Ph.D.

Peer-Reviewed Articles

1. Tse JR, Khalatbari S, Yosef M, Abitbol C, Abou Elkassem AM, Albayrak E, Baroni RH, Bhayana R, Cao JJ, Coelho FMA, Houshmand S, Kamaya A, Krajewski KM, Krishna S, Lee SJ, Mussi TC, Prabhakar S, Schieda N, Shen L, Shinagare AB, Silverman SG, Smith AD, Sonn GA, Taherzadeh M, Wang ZJ, Warner JD, Wentland AL, Pedrosa I, Davenport MS. Diagnostic Accuracy of Bosniak v2019 for Predicting Cancer and Unfavorable Histology in Class III-IV Cystic Renal Masses. Radiology 320(3):e252603, 2026. e-Pub 2026. PMID: 42808899.
2. Davenport, MS, Pedrosa, I. Invited Commentary. Radiographics : a review publication of the Radiological Society of North America, Inc 46(7):e250232, 2026. e-Pub 2026. PMID: 42241324.
3. Haddad, G, Guo, J, Xi, Y, Albayrak, E, Huseni, M, Hamidi, H, Banchereau, R, Kadel, EE, Dubey, S, Carter, C, Kapur, P, Brugarolas, J, Pedrosa, I. Metastatic tropism of molecularly defined clear-cell renal cell carcinoma clusters. Journal of Clinical Investigation 136(10), 2026. e-Pub 2026. PMID: 42138077.
4. Wang, X, Keupp, J, Dimitrov, IE, Madhuranthakam, AJ, Udayakumar, D, Taherzadeh, M, Albayrak, E, Moe, OW, Kapur, P, Lenkinski, RE, Pedrosa, I, Vinogradov, E. Evaluation of renal masses with CEST MRI. Magnetic resonance in medicine 94(6):2374-2387, 2025. e-Pub 2025. PMID: 40693363.
5. Mal, A, Xie, B, Gray, Z, Small, C, Ramanand, SG, Gao, Y, Toffessi-Tcheuyap, V, Debnath, S, Christie, A, Miyata, J, Jackson, B, Zhong, H, Gao, B, Lohrey, J, Maalouf, NM, Reddy, S, Minna, J, Pedrosa, I, Sun, X, Mani, RS, Kapur, P, Brugarolas, J. HIF-2–Dependent Regulation of PTHrP and Paraneoplastic Hypercalcemia in Aggressive Clear-Cell Renal Cell Carcinoma. Cancer discovery 15(12):2485-2504, 2025. e-Pub 2025. PMID: 41065553.
6. Kapur P, Christie A, Jarmale V, Tahmasebi F, Xie B, Miyata J, Rakheja D, Cadeddu JA, Margulis V, Hammers H, Zhang T, Pedrosa I, Brugarolas J, Rajaram S. Radiologic, Pathologic, and Deep Learning Predictors of Response to Immune Checkpoint Blockade in Renal Cell Carcinoma Patients Undergoing Post-Treatment Nephrectomy. medRxiv, 2025. e-Pub 2025. PMID: 41332849.
7. Parrott D, Yuan Q, Pinho D, Xi Y, Costa DN, De Leon AD, Dakanali M, Sun X, Oz OK, Bowen S, Rofsky NM, Mathews D, Pedrosa I. Characterization of suspicious prostate lesions at multiparametric MRI with dynamic (68) Ga-Gozetotide PET/CT. EJNMMI Rep 9(1):35, 2025. e-Pub 2025. PMID: 41077599.
8. Gao, B, Kanabur, P, Campi, R, Tran, M, Landman, J, Pedrosa, I, Challacombe, B, Wah, TM, Siva, S, Jewett, M, Stewart, GD, Shuch, B, Clayman, RV. ‘BJUI Clinical Dilemma’. BJU International 135(3):371-379, 2025. e-Pub 2025. PMID: 39761985.
9. Guo, J, Haddad, G, Xi, Y, Hinojosa, L, Hulsey, K, Albayrak, E, Pedrosa, I. Deep Learning Identification of Clear Cell Renal Cell Carcinoma on MR Imaging. Journal of computer assisted tomography Publish Ahead of Print, 2025. e-Pub 2025. PMID: 41656681.
10. Buelo CJ, Velikina J, Mao L, Zhao R, Yuan Q, Ghasabeh MA, Ruschke S, Karampinos DC, Harris DT, Mattison RJ, Jeng MR, Pedrosa I, Kamel IR, Vasanawala S, Yokoo T, Reeder SB, Hernando D. Multicenter, multivendor validation of liver quantitative susceptibility mapping in patients with iron overload at 1.5 T and 3 T. Magn Reson Med 93(1):330-340, 2025. e-Pub 2025. PMID: 39238238.
11. Simchick G, Zhao R, Yuan Q, Ghasabeh MA, Ruschke S, Karampinos DC, Harris DT, do Vale Souza R, Mattison RJ, Jeng MR, Pedrosa I, Kamel IR, Vasanawala S, Yokoo T, Reeder SB, Hernando D. Practical Application of Multivendor MRI-Based R2* Mapping for Liver Iron Quantification at 1.5 T and 3.0 T. J Magn Reson Imaging 61(1):150-165, 2025. e-Pub 2025. PMID: 38662618.
12. Khene ZE, Tachibana I, Bertail T, Fleury R, Bhanvadia R, Kapur P, Rajaram S, Guo J, Christie A, Pedrosa I, Lotan Y, Margulis V. Clinical application of radiomics for the prediction of treatment outcome and survival in patients with renal cell carcinoma: a systematic review. World J Urol 42(1):541, 2024. e-Pub 2024. PMID: 39325194.
13. Bezwada D, Perelli L, Lesner NP, Cai L, Brooks B, Wu Z, Vu HS, Sondhi V, Cassidy DL, Kasitinon S, Kelekar S, Cai F, Aurora AB, Patrick M, Leach A, Ghandour R, Zhang Y, Do D, McDaniel P, Sudderth J, Dumesnil D, House S, Rosales T, Poole AM, Lotan Y, Woldu S, Bagrodia A, Meng X, Cadeddu JA, Mishra P, Garcia-Bermudez J, Pedrosa I, Kapur P, Courtney KD, Malloy CR, Genovese G, Margulis V, DeBerardinis RJ. Mitochondrial complex I promotes kidney cancer metastasis. Nature 633(8031):923-931, 2024. e-Pub 2024. PMID: 39143213.
14. Kim, Y, Bu, S, Tao, C, Bae, KT, Steinman, TI, Wei, J, Czarnecki, PG, Pedrosa, I, Braun, W, Nurko, S, Remer, EM, Chapman, AB, Martin, D, Rahbari-Oskoui, F, Mittal, P, Torres, VE, Hogan, MC, El-Zoghby, Z, Harris, PC, Glockner, J, King, BF, Perrone, RD, Halin, NJ, Miskulin, DC, Schrier, RW, Brosnahan, G, Gitomer, B, Kelleher, C, Masoumi, A, Patel, N, Winklhofer, FT, Grantham, JJ, Yu, AS, Wang, C, Wetzel, LH, Moore, CG, Bost, J, Bae, K, Abebe, KZ, Miller, JP, Thompson, PA, Briggs, J, Flessner, MF, Meyers, CM, Star, RA, Shayman, J, Henrich, W, Greene, TH, Leonard, M, McCullough, P. Deep Learning–Based Automated Imaging Classification of ADPKD. Kidney International Reports 9(6):1802-1809, 2024. e-Pub 2024. PMID: 38899202.
15. Vazquez LC, Xi Y, Rasmussen RG, Venzor JER, Kapur P, Zhong H, Dai JC, Morgan TN, Cadeddu JA, Pedrosa I. Characterization of Demographical Histologic Diversity in Small Renal Masses With the Clear Cell Likelihood Score. J Comput Assist Tomogr 48(3):370-377, 2024. e-Pub 2024. PMID: 38213063.
16. Wang K, Karalis JD, Elamir A, Bifolco A, Wachsmann M, Capretti G, Spaggiari P, Enrico S, Balasubramanian K, Fatimah N, Pontecorvi G, Nebbia M, Yopp A, Kaza R, Pedrosa I, Zeh H 3rd, Polanco P, Zerbi A, Wang J, Aguilera T, Ligorio M. Delta Radiomic Features Predict Resection Margin Status and Overall Survival in Neoadjuvant-Treated Pancreatic Cancer Patients. Ann Surg Oncol 31(4):2608-2620, 2024. e-Pub 2024. PMID: 38151623.
17. Prakasam G, Mishra A, Christie A, Miyata J, Carrillo D, Tcheuyap VT, Ye H, Do QN, Wang Y, Reig Torras O, Butti R, Zhong H, Gagan J, Jones KB, Carroll TJ, Modrusan Z, Durinck S, Requena-Komuro MC, Williams NS, Pedrosa I, Wang T, Rakheja D, Kapur P, Brugarolas J. Comparative genomics incorporating translocation renal cell carcinoma mouse model reveals molecular mechanisms of tumorigenesis. J Clin Invest 134(7), 2024. e-Pub 2024. PMID: 38386415.
18. Recchimuzzi DZ, Diaz de Leon A, Pedrosa I, Travalini D, Latin H, Goldberg K, Meng X, Begovic J, Rayan J, Roehrborn CG, Rofsky NM, Costa DN. Direct MRI-guided In-Bore Targeted Biopsy of the Prostate: A Step-by-Step How To and Lessons Learned. Radiographics 44(2):e230142, 2024. e-Pub 2024. PMID: 38175803.
19. Venishetty N, Taylor J, Xi Y, Howard JM, Ng YS, Wong D, Woldu SL, De Leon AD, Pedrosa I, Margulis V, Bagrodia A. Testicular Radiomics To Predict Pathology At Time of Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Tumor. Clin Genitourin Cancer 22(1):33-37, 2024. e-Pub 2024. PMID: 37468341.
20. Guo, J, Goyal, M, Xi, Y, Hinojosa, L, Haddad, G, Albayrak, E, Pedrosa, I. Style Transfer–assisted Deep Learning Method for Kidney Segmentation at Multiphase MRI. Radiology: Artificial Intelligence 5(6), 2023. e-Pub 2023. PMID: 38074795.
21. Guo J, Goyal M, Xi Y, Hinojosa L, Haddad G, Albayrak E, Pedrosa I. Style Transfer-assisted Deep Learning Method for Kidney Segmentation at Multiphase MRI. Radiol Artif Intell 5(6):e230043, 2023. e-Pub 2023. PMID: 38074795.
22. Hannan R, McLaughlin MF, Pop LM, Pedrosa I, Kapur P, Garant A, Ahn C, Christie A, Zhu J, Wang T, Robles L, Durakoglugil D, Woldu S, Margulis V, Gahan J, Brugarolas J, Timmerman R, Cadeddu J. Phase 2 Trial of Stereotactic Ablative Radiotherapy for Patients with Primary Renal Cancer. Eur Urol 84(3):275-286, 2023. e-Pub 2023. PMID: 36898872.
23. Shen L, Tse JR, Lemieux S, Yoon L, Mullane PC, Liang T, Davenport MS, Pedrosa I, Silverman SG. Risk of malignancy in T1-hyperintense Bosniak version 2019 class II and IIF cystic renal masses. Abdom Radiol (NY) 48(8):2636-2648, 2023. e-Pub 2023. PMID: 37202641.
24. Patel VM, Elias R, Asokan A, Sharma A, Christie A, Pedrosa I, Chiu H, Reznik S, Hannan R, Timmerman R, Brugarolas J. Life-threatening hemoptysis in patients with metastatic kidney cancer. Clin Genitourin Cancer 21(4):497-506, 2023. e-Pub 2023. PMID: 37045713.
25. Bezwada D, Lesner NP, Brooks B, Vu HS, Wu Z, Cai L, Kasitinon S, Kelekar S, Cai F, Aurora AB, Patrick M, Leach A, Ghandour R, Zhang Y, Do D, Sudderth J, Dumesnil D, House S, Rosales T, Poole AM, Lotan Y, Woldu S, Bagrodia A, Meng X, Cadeddu JA, Mishra P, Pedrosa I, Kapur P, Courtney KD, Malloy CR, Margulis V, DeBerardinis RJ. Mitochondrial metabolism in primary and metastatic human kidney cancers. bioRxiv, 2023. e-Pub 2023. PMID: 36798172.
26. Hernando D, Zhao R, Yuan Q, Aliyari Ghasabeh M, Ruschke S, Miao X, Karampinos DC, Mao L, Harris DT, Mattison RJ, Jeng MR, Pedrosa I, Kamel IR, Vasanawala S, Yokoo T, Reeder SB. Multicenter Reproducibility of Liver Iron Quantification with 1.5-T and 3.0-T MRI. Radiology 306(2):e213256, 2023. e-Pub 2023. PMID: 36194113.
27. Costa DN, Meng X, Tverye A, Bagrodia A, Recchimuzzi DZ, Xi Y, Arraj P, Shah RB, Subramanian N, de Leon AD, Roehrborn CG, Rofsky NM, Chen H, Pedrosa I. Preoperative Multiparametric Prostate Magnetic Resonance Imaging Structured Report Informs Risk for Positive Apical Surgical Margins During Radical Prostatectomy. J Comput Assist Tomogr 47(1):38-44, 2023. e-Pub 2023. PMID: 35995580.
28. Ma Y, Joyce A, Brandenburg O, Saatchi F, Stevens C, Toffessi Tcheuyap V, Christie A, Do QN, Fatunde O, Macchiaroli A, Wong SC, Woolford L, Yousuf Q, Miyata J, Carrillo D, Onabolu O, McKenzie T, Mishra A, Hardy T, He W, Li D, Ivanishev A, Zhang Q, Pedrosa I, Kapur P, Schluep T, Kanner SB, Hamilton J, Brugarolas J. HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans. Clin Cancer Res 28(24):5405-5418, 2022. e-Pub 2022. PMID: 36190432.
29. Hannan R, Christensen M, Christie A, Garant A, Pedrosa I, Robles L, Mannala S, Wang C, Hammers H, Arafat W, Courtney K, Bowman IA, Sher D, Ahn C, Cole S, Choy H, Timmerman R, Brugarolas J. Stereotactic Ablative Radiation for Systemic Therapy-naive Oligometastatic Kidney Cancer. Eur Urol Oncol 5(6):695-703, 2022. e-Pub 2022. PMID: 35985982.
30. Kapur P, Zhong H, Araj E, Christie A, Cai Q, Kim D, Miyata J, Tcheuyap VT, Brandenburg O, Carrillo D, Pedrosa I, Brugarolas J, Cadeddu JA. Predicting Oncologic Outcomes in Small Renal Tumors. Eur Urol Oncol 5(6):687-694, 2022. e-Pub 2022. PMID: 36115820.
31. Cai Q, Costa DN, Metter CK, Goldberg K, Roehrborn CG, Cadeddu J, Pedrosa I, Meng X, Mostardeiro TR, Shah RB. Sensitivity of multiparametric MRI and targeted biopsy for detection of adverse pathologies (Cribriform gleason pattern 4 and intraductal carcinoma): Correlation of detected and missed prostate cancer foci with whole mount histopathology. Urol Oncol 40(10):452.e1-452.e8, 2022. e-Pub 2022. PMID: 36008255.
32. Schieda N, Davenport MS, Silverman SG, Bagga B, Barkmeier D, Blank Z, Curci NE, Doshi AM, Downey RT, Edney E, Granader E, Gujrathi I, Hibbert RM, Hindman N, Walsh C, Ramsay T, Shinagare AB, Pedrosa I. Multicenter Evaluation of Multiparametric MRI Clear Cell Likelihood Scores in Solid Indeterminate Small Renal Masses. Radiology 303(3):590-599, 2022. e-Pub 2022. PMID: 35289659.
33. Rasmussen R, Sanford T, Parwani AV, Pedrosa I. Artificial Intelligence in Kidney Cancer. Am Soc Clin Oncol Educ Book 42:1-11, 2022. e-Pub 2022. PMID: 35580292.
34. Freifeld Y, Pedrosa I, Mclaughlin M, Correa RM, Louie AV, Maldonado JA, Tang C, Kadow B, Kutikov A, Uzzo RG, Porta C, Bucknell NW, Siva S, Brugarolas J, Margulis V, Timmerman R, Hannan R. Stereotactic ablative radiation therapy for renal cell carcinoma with inferior vena cava tumor thrombus. Urol Oncol 40(4):166.e9-166.e13, 2022. e-Pub 2022. PMID: 35144866.
35. Kapur P, Gao M, Zhong H, Chintalapati S, Mitui M, Barnes SD, Zhou Q, Miyata J, Carrillo D, Malladi VS, Rakheja D, Pedrosa I, Xu L, Kinch L, Brugarolas J. Germline and sporadic mTOR pathway mutations in low-grade oncocytic tumor of the kidney. Mod Pathol 35(3):333-343, 2022. e-Pub 2022. PMID: 34538873.
36. Huang J, Guo J, Pedrosa I, Fei B. Deep Learning-based Deformable Registration of Dynamic Contrast-Enhanced MR Images of the Kidney. Proc SPIE Int Soc Opt Eng 12034, 2022. e-Pub 2022. PMID: 36793654.
37. Jia L, Panwar V, Parmley M, Lucas E, Pedrosa I, Kapur P. Retroperitoneal Sclerosing Angiomyolipoma with Long-Term Follow up: A Case Report with Unique Clinicopathologic and Genomic Profile. Int J Surg Pathol 30(1):86-90, 2022. e-Pub 2022. PMID: 34106015.
38. Rasmussen RG, Xi Y, Sibley RC 3rd, Lee CJ, Cadeddu JA, Pedrosa I. Association of Clear Cell Likelihood Score on MRI and Growth Kinetics of Small Solid Renal Masses on Active Surveillance. AJR Am J Roentgenol 218(1):101-110, 2022. e-Pub 2022. PMID: 34286596.
39. Guo J, Odu A, Pedrosa I. Deep learning kidney segmentation with very limited training data using a cascaded convolution neural network. PLoS One 17(5):e0267753, 2022. e-Pub 2022. PMID: 35533181.
40. Sharma A, Elias R, Christie A, Williams NS, Pedrosa I, Bjarnason GA, Brugarolas J. Extended disease control with unconventional cabozantinib dose increase in metastatic renal cell carcinoma. Kidney Cancer 6(1):69-79, 2022. e-Pub 2022. PMID: 36743424.
41. Hannan R, Mohamad O, Diaz de Leon A, Manna S, Pop LM, Zhang Z, Mannala S, Christie A, Christley S, Monson N, Ishihara D, Hsu EJ, Ahn C, Kapur P, Chen M, Arriaga Y, Courtney K, Cantarel B, Wakeland EK, Fu YX, Pedrosa I, Cowell L, Wang T, Margulis V, Choy H, Timmerman RD, Brugarolas J. Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma. Clin Cancer Res 27(24):6716-6725, 2021. e-Pub 2021. PMID: 34551906.
42. Elias R, Tcheuyap VT, Kaushik AK, Singla N, Gao M, Reig Torras O, Christie A, Mulgaonkar A, Woolford L, Stevens C, Kettimuthu KP, Pavia-Jimenez A, Boroughs LK, Joyce A, Dakanali M, Notgrass H, Margulis V, Cadeddu JA, Pedrosa I, Williams NS, Sun X, DeBerardinis RJ, Oz OK, Zhong H, Seshagiri S, Modrusan Z, Cantarel BL, Kapur P, Brugarolas J. A renal cell carcinoma tumorgraft platform to advance precision medicine. Cell Rep 37(8):110055, 2021. e-Pub 2021. PMID: 34818533.
43. Kim K, Zhou Q, Christie A, Stevens C, Ma Y, Onabolu O, Chintalapati S, Mckenzie T, Tcheuyap VT, Woolford L, Zhang H, Singla N, Parida PK, Marquez-Palencia M, Pedrosa I, Margulis V, Sagalowsky A, Xie Z, Wang T, Durinck S, Modrusan Z, Seshagiri S, Kapur P, Brugarolas J, Malladi S. Determinants of renal cell carcinoma invasion and metastatic competence. Nat Commun 12(1):5760, 2021. e-Pub 2021. PMID: 34608135.
44. Udayakumar D, Zhang Z, Xi Y, Dwivedi DK, Fulkerson M, Haldeman S, McKenzie T, Yousuf Q, Joyce A, Hajibeigi A, Notgrass H, de Leon AD, Yuan Q, Lewis MA, Madhuranthakam AJ, Sibley RC, Elias R, Guo J, Christie A, McKay RM, Cadeddu JA, Bagrodia A, Margulis V, Brugarolas J, Wang T, Kapur P, Pedrosa I. Deciphering Intratumoral Molecular Heterogeneity in Clear Cell Renal Cell Carcinoma with a Radiogenomics Platform. Clin Cancer Res 27(17):4794-4806, 2021. e-Pub 2021. PMID: 34210685.
45. Smith WC, Khatri G, Dunn SH, Zeidan N, Browning TG, Kubiliun N, Mansour JC, Minter RM, Vu L, Coleman VL, Pedrosa I, Leyendecker JR. Facilitating Surveillance of Incidental Findings Using a Novel Reporting Template: Proof of Concept in Patients With Pancreatic Abnormalities. J Am Coll Radiol 18(9):1246-1257, 2021. e-Pub 2021. PMID: 34283988.
46. Wang X, Udayakumar D, Xi Y, Rofsky NM, Pedrosa I, Madhuranthakam AJ. Single-shot RARE with Dixon: Application to robust abdominal imaging with uniform fat and water separation at 3T. Magn Reson Med 86(3):1463-1471, 2021. e-Pub 2021. PMID: 33929055.
47. Costa DN, Jia L, Subramanian N, Xi Y, Rofsky NM, Recchimuzzi DZ, de Leon AD, Arraj P, Pedrosa I. Prospective PI-RADS v2.1 Atypical Benign Prostatic Hyperplasia Nodules With Marked Restricted Diffusion: Detection of Clinically Significant Prostate Cancer on Multiparametric MRI. AJR Am J Roentgenol 217(2):395-403, 2021. e-Pub 2021. PMID: 32876473.
48. Margulis V, Freifeld Y, Pop LM, Manna S, Kapur P, Pedrosa I, Christie A, Mohamad O, Mannala S, Singla N, Wait M, Bagrodia A, Woldu SL, Gahan J, Brugarolas J, Timmerman R, Hannan R. Neoadjuvant SABR for Renal Cell Carcinoma Inferior Vena Cava Tumor Thrombus-Safety Lead-in Results of a Phase 2 Trial. Int J Radiat Oncol Biol Phys 110(4):1135-1142, 2021. e-Pub 2021. PMID: 33549705.
49. Kapur P, Gao M, Zhong H, Rakheja D, Cai Q, Pedrosa I, Margulis V, Xu L, Kinch L, Brugarolas J. Eosinophilic Vacuolated Tumor of the Kidney: A Review of Evolving Concepts in This Novel Subtype With Additional Insights From a Case With MTOR Mutation and Concomitant Chromosome 1 Loss. Adv Anat Pathol 28(4):251-257, 2021. e-Pub 2021. PMID: 34009776.
50. Schieda N, Davenport MS, Krishna S, Edney EA, Pedrosa I, Hindman N, Baroni RH, Curci NE, Shinagare A, Silverman SG. Bosniak Classification of Cystic Renal Masses, Version 2019: A Pictorial Guide to Clinical Use. Radiographics 41(3):814-828, 2021. e-Pub 2021. PMID: 33861647.
51. Setoodeh S, Palsgrove DN, Park JY, Pedrosa I, Kapur P, Jia L. Primary Renal Sarcoma With BCOR-CCNB3 Gene Fusion in an 18-Year-Old Male: A Rare Lesion With a Diagnostic Quandary. Int J Surg Pathol 29(2):194-197, 2021. e-Pub 2021. PMID: 32648496.
52. Khatri G, Kumar NM, Xi Y, Smith W, Bacsu C, Bailey AA, Zimmern PE, Pedrosa I. Defecation versus pre- and post-defecation Valsalva maneuvers for dynamic MR assessment of pelvic floor dysfunction. Abdom Radiol (NY) 46(4):1362-1372, 2021. e-Pub 2021. PMID: 31494706.
53. Subramanian N, Recchimuzzi DZ, Xi Y, Diaz de Leon A, Chen H, Xie D, Goldberg K, Rofsky NM, Pedrosa I, Costa DN. Impact of the Number of Cores on the Prostate Cancer Detection Rate in Men Undergoing in-Bore Magnetic Resonance Imaging-Guided Targeted Biopsies. J Comput Assist Tomogr 45(2):203-209, 2021. e-Pub 2021. PMID: 33273160.
54. Costa DN, Cai Q, Xi Y, Recchimuzzi DZ, Subramanian N, Bagrodia A, Rofsky NM, Roehrborn CG, Hornberger B, Shah RB, Goldberg K, Diaz de Leon A, Pedrosa I. Gleason Grade Group Concordance between Preoperative Targeted Biopsy and Radical Prostatectomy Histopathologic Analysis: A Comparison Between In-Bore MRI-guided and MRI-Transrectal US Fusion Prostate Biopsies. Radiol Imaging Cancer 3(2):e200123, 2021. e-Pub 2021. PMID: 33817652.
55. Dwivedi DK, Xi Y, Kapur P, Madhuranthakam AJ, Lewis MA, Udayakumar D, Rasmussen R, Yuan Q, Bagrodia A, Margulis V, Fulkerson M, Brugarolas J, Cadeddu JA, Pedrosa I. Magnetic Resonance Imaging Radiomics Analyses for Prediction of High-Grade Histology and Necrosis in Clear Cell Renal Cell Carcinoma: Preliminary Experience. Clin Genitourin Cancer 19(1):12-21.e1, 2021. e-Pub 2021. PMID: 32669212.
56. Tsai LL, Bhatt RS, Strob MF, Jegede OA, Sun MRM, Alsop DC, Catalano P, McDermott D, Robson PM, Atkins MB, Pedrosa I. Arterial Spin Labeled Perfusion MRI for the Evaluation of Response to Tyrosine Kinase Inhibition Therapy in Metastatic Renal Cell Carcinoma. Radiology 298(2):332-340, 2021. e-Pub 2021. PMID: 33258745.
57. Shinagare AB, Davenport MS, Park H, Pedrosa I, Remer EM, Chandarana H, Doshi AM, Schieda N, Smith AD, Vikram R, Wang ZJ, Silverman SG. Lexicon for renal mass terms at CT and MRI: a consensus of the society of abdominal radiology disease-focused panel on renal cell carcinoma. Abdom Radiol (NY) 46(2):703-722, 2021. e-Pub 2021. PMID: 32809055.
58. Steinberg RL, Rasmussen RG, Johnson BA, Ghandour R, De Leon AD, Xi Y, Yokoo T, Kim S, Kapur P, Cadeddu JA, Pedrosa I. Prospective performance of clear cell likelihood scores (ccLS) in renal masses evaluated with multiparametric magnetic resonance imaging. Eur Radiol 31(1):314-324, 2021. e-Pub 2021. PMID: 32770377.
59. Gerber DE, Putnam WC, Fattah FJ, Kernstine KH, Brekken RA, Pedrosa I, Skelton R, Saltarski JM, Lenkinski RE, Leff RD, Ahn C, Padmanabhan C, Chembukar V, Kasiri S, Kallem RR, Subramaniyan I, Yuan Q, Do QN, Xi Y, Reznik SI, Pelosof L, Faubert B, DeBerardinis RJ, Kim J. Concentration-dependent Early Antivascular and Antitumor Effects of Itraconazole in Non-Small Cell Lung Cancer. Clin Cancer Res 26(22):6017-6027, 2020. e-Pub 2020. PMID: 32847935.
60. Patel V, Elias R, Formella J, Schwartzman W, Christie A, Cai Q, Malladi V, Kapur P, Vazquez M, McKay R, Pedrosa I, Hannan R, Hammers H, Brugarolas J. Acute interstitial nephritis, a potential predictor of response to immune checkpoint inhibitors in renal cell carcinoma. J Immunother Cancer 8(2), 2020. e-Pub 2020. PMID: 33139246.
61. Davenport MS, Bruno MA, Iyer RS, Johnson AM, Herrera R, Nicola GN, Ortiz D, Pedrosa I, Policeni B, Recht MP, Willis M, Zuley ML, Weinstein S. ACR Statement on Safe Resumption of Routine Radiology Care During the Coronavirus Disease 2019 (COVID-19) Pandemic. J Am Coll Radiol 17(7):839-844, 2020. e-Pub 2020. PMID: 32442427.
62. Pirasteh A, Johnson B, Dimitrov IE, Costa DN, Diaz de Leon A, Xi Y, Madhuranthakam AJ, Pedrosa I. Turbo Spin-Echo Diffusion-Weighted Imaging in Prostate Magnetic Resonance Imaging of Men With Pelvic Hardware. J Comput Assist Tomogr 44(4):519-526, 2020. e-Pub 2020. PMID: 32697522.
63. Pedrosa I, Browning T, Kwon JK, Morriss M, Matsler L, Pinho MC, Lamus D, Pillai A, Karow SP, Garinn J, Brewington C, Zeikus E, Rofsky NM. Response to COVID-19: Minimizing Risks, Addressing Challenges and Maintaining Operations in a Complex Academic Radiology Department. J Comput Assist Tomogr 44(4):479-484, 2020. e-Pub 2020. PMID: 32433251.
64. Singla N, Xie Z, Zhang Z, Gao M, Yousuf Q, Onabolu O, McKenzie T, Tcheuyap VT, Ma Y, Choi J, McKay R, Christie A, Torras OR, Bowman IA, Margulis V, Pedrosa I, Przybycin C, Wang T, Kapur P, Rini B, Brugarolas J. Pancreatic tropism of metastatic renal cell carcinoma. JCI Insight 5(7), 2020. e-Pub 2020. PMID: 32271170.
65. Courtney KD, Ma Y, Diaz de Leon A, Christie A, Xie Z, Woolford L, Singla N, Joyce A, Hill H, Madhuranthakam AJ, Yuan Q, Xi Y, Zhang Y, Chang J, Fatunde O, Arriaga Y, Frankel AE, Kalva S, Zhang S, McKenzie T, Reig Torras O, Figlin RA, Rini BI, McKay RM, Kapur P, Wang T, Pedrosa I, Brugarolas J. HIF-2 Complex Dissociation, Target Inhibition, and Acquired Resistance with PT2385, a First-in-Class HIF-2 Inhibitor, in Patients with Clear Cell Renal Cell Carcinoma. Clin Cancer Res 26(4):793-803, 2020. e-Pub 2020. PMID: 31727677.
66. Greenberg TD, Hoff MN, Gilk TB, Jackson EF, Kanal E, McKinney AM, Och JG, Pedrosa I, Rampulla TL, Reeder SB, Rogg JM, Shellock FG, Watson RE, Weinreb JC, Hernandez D. ACR guidance document on MR safe practices: Updates and critical information 2019. J Magn Reson Imaging 51(2):331-338, 2020. e-Pub 2020. PMID: 31355502.
67. Nery F, Buchanan CE, Harteveld AA, Odudu A, Bane O, Cox EF, Derlin K, Gach HM, Golay X, Gutberlet M, Laustsen C, Ljimani A, Madhuranthakam AJ, Pedrosa I, Prasad PV, Robson PM, Sharma K, Sourbron S, Taso M, Thomas DL, Wang DJJ, Zhang JL, Alsop DC, Fain SB, Francis ST, Fernandez-Seara MA. Consensus-based technical recommendations for clinical translation of renal ASL MRI. MAGMA 33(1):141-161, 2020. e-Pub 2020. PMID: 31833014.
68. Mendichovszky I, Pullens P, Dekkers I, Nery F, Bane O, Pohlmann A, de Boer A, Ljimani A, Odudu A, Buchanan C, Sharma K, Laustsen C, Harteveld A, Golay X, Pedrosa I, Alsop D, Fain S, Caroli A, Prasad P, Francis S, Sigmund E, Fernandez-Seara M, Sourbron S. Technical recommendations for clinical translation of renal MRI: a consensus project of the Cooperation in Science and Technology Action PARENCHIMA. MAGMA 33(1):131-140, 2020. e-Pub 2020. PMID: 31628564.
69. Khatri G, Pedrosa I, Ananthakrishnan L, de Leon AD, Fetzer DT, Leyendecker J, Singal AG, Xi Y, Yopp A, Yokoo T. Abbreviated-protocol screening MRI vs. complete-protocol diagnostic MRI for detection of hepatocellular carcinoma in patients with cirrhosis: An equivalence study using LI-RADS v2018. J Magn Reson Imaging 51(2):415-425, 2020. e-Pub 2020. PMID: 31209978.
70. Cai Q, Christie A, Rajaram S, Zhou Q, Araj E, Chintalapati S, Cadeddu J, Margulis V, Pedrosa I, Rakheja D, McKay RM, Brugarolas J, Kapur P. Ontological analyses reveal clinically-significant clear cell renal cell carcinoma subtypes with convergent evolutionary trajectories into an aggressive type. EBioMedicine 51:102526, 2020. e-Pub 2020. PMID: 31859241.
71. Yokoo T, Singal AG, Diaz de Leon A, Ananthakrishnan L, Fetzer DT, Pedrosa I, Khatri G. Prevalence and clinical significance of discordant LI-RADS((R)) observations on multiphase contrast-enhanced MRI in patients with cirrhosis. Abdom Radiol (NY) 45(1):177-187, 2020. e-Pub 2020. PMID: 31342103.
72. Johnson BA, Kim S, Steinberg RL, de Leon AD, Pedrosa I, Cadeddu JA. Diagnostic performance of prospectively assigned clear cell Likelihood scores (ccLS) in small renal masses at multiparametric magnetic resonance imaging. Urol Oncol 37(12):941-946, 2019. e-Pub 2019. PMID: 31540830.
73. Greer JS, Wang X, Wang Y, Pinho MC, Maldjian JA, Pedrosa I, Madhuranthakam AJ. Robust pCASL perfusion imaging using a 3D Cartesian acquisition with spiral profile reordering (CASPR). Magn Reson Med 82(5):1713-1724, 2019. e-Pub 2019. PMID: 31231894.
74. Kumar NM, Khatri G, Christie AL, Sims R, Pedrosa I, Zimmern PE. Supine magnetic resonance defecography for evaluation of anterior compartment prolapse: Comparison with upright voiding cystourethrogram. Eur J Radiol 117:95-101, 2019. e-Pub 2019. PMID: 31307659.
75. Costa DN, Goldberg K, Leon AD, Lotan Y, Xi Y, Aziz M, Freifeld Y, Margulis V, Raj G, Roehrborn CG, Hornberger B, Desai N, Bagrodia A, Francis F, Pedrosa I, Cadeddu JA. Magnetic Resonance Imaging-guided In-bore and Magnetic Resonance Imaging-transrectal Ultrasound Fusion Targeted Prostate Biopsies: An Adjusted Comparison of Clinically Significant Prostate Cancer Detection Rate. Eur Urol Oncol 2(4):397-404, 2019. e-Pub 2019. PMID: 31277776.
76. Schieda N, Davenport MS, Pedrosa I, Shinagare A, Chandarana H, Curci N, Doshi A, Israel G, Remer E, Wang J, Silverman SG. Renal and adrenal masses containing fat at MRI: Proposed nomenclature by the society of abdominal radiology disease-focused panel on renal cell carcinoma. J Magn Reson Imaging 49(4):917-926, 2019. e-Pub 2019. PMID: 30693607.
77. Davenport MS, Hu EM, Zhang A, Shinagare AB, Smith AD, Pedrosa I, Kaffenberger SD, Silverman SG. Standardized report template for indeterminate renal masses at CT and MRI: a collaborative product of the SAR Disease-Focused Panel on Renal Cell Carcinoma. Abdom Radiol (NY) 44(4):1423-1429, 2019. e-Pub 2019. PMID: 30511089.
78. Andrews S, Yuan Q, Bailey A, Xi Y, Chopra R, Staruch R, Pedrosa I. Multiparametric MRI Characterization of Funaki Types of Uterine Fibroids Considered for MR-Guided High-Intensity Focused Ultrasound (MR-HIFU) Therapy. Acad Radiol 26(4):e9-e17, 2019. e-Pub 2019. PMID: 30064919.
79. Freifeld Y, Diaz de Leon A, Xi Y, Pedrosa I, Roehrborn CG, Lotan Y, Francis F, Costa DN. Diagnostic Performance of Prospectively Assigned Likert Scale Scores to Determine Extraprostatic Extension and Seminal Vesicle Invasion With Multiparametric MRI of the Prostate. AJR Am J Roentgenol 212(3):576-581, 2019. e-Pub 2019. PMID: 30589381.
80. Costa DN, Xi Y, Aziz M, Passoni N, Shakir N, Goldberg K, Francis F, Roehrborn CG, Leon AD, Pedrosa I. Prospective Inclusion of Apparent Diffusion Coefficients in Multiparametric Prostate MRI Structured Reports: Discrimination of Clinically Insignificant and Significant Cancers. AJR Am J Roentgenol 212(1):109-116, 2019. e-Pub 2019. PMID: 30383404.
81. Freifeld Y, Xi Y, Passoni N, Woldu S, Hornberger B, Goldberg K, Bagrodia A, Raj G, Margulis V, Cadeddu JA, Lotan Y, Francis F, Pedrosa I, G Roehrborn C, Costa DN. Optimal sampling scheme in men with abnormal multiparametric MRI undergoing MRI-TRUS fusion prostate biopsy. Urol Oncol 37(1):57-62, 2019. e-Pub 2019. PMID: 30446460.
82. Elias R, Kapur P, Pedrosa I, Brugarolas J. Renal Cell Carcinoma Pseudoprogression with Clinical Deterioration: To Hospice and Back. Clin Genitourin Cancer 16(6):485-488, 2018. e-Pub 2018. PMID: 30100272.
83. Hu EM, Zhang A, Silverman SG, Pedrosa I, Wang ZJ, Smith AD, Chandarana H, Doshi A, Shinagare AB, Remer EM, Kaffenberger SD, Miller DC, Davenport MS. Multi-institutional analysis of CT and MRI reports evaluating indeterminate renal masses: comparison to a national survey investigating desired report elements. Abdom Radiol (NY) 43(12):3493-3502, 2018. e-Pub 2018. PMID: 29666953.
84. Pirasteh A, Yuan Q, Hernando D, Reeder SB, Pedrosa I, Yokoo T. Inter-method reproducibility of biexponential R(2) MR relaxometry for estimation of liver iron concentration. Magn Reson Med 80(6):2691-2701, 2018. e-Pub 2018. PMID: 29770484.
85. Courtney KD, Bezwada D, Mashimo T, Pichumani K, Vemireddy V, Funk AM, Wimberly J, McNeil SS, Kapur P, Lotan Y, Margulis V, Cadeddu JA, Pedrosa I, DeBerardinis RJ, Malloy CR, Bachoo RM, Maher EA. Isotope Tracing of Human Clear Cell Renal Cell Carcinomas Demonstrates Suppressed Glucose Oxidation In Vivo. Cell Metab 28(5):793-800.e2, 2018. e-Pub 2018. PMID: 30146487.
86. Chen X, Zhou Z, Hannan R, Thomas K, Pedrosa I, Kapur P, Brugarolas J, Mou X, Wang J. Reliable gene mutation prediction in clear cell renal cell carcinoma through multi-classifier multi-objective radiogenomics model. Phys Med Biol 63(21):215008, 2018. e-Pub 2018. PMID: 30277889.
87. Diaz de Leon A, Leyendecker JR, Otero-Muinelo S, Grewal H, Xi Y, Francis F, Pedrosa I, Costa DN. Reproducibility of Index Lesion Size and Mean Apparent Diffusion Coefficient Values Measured by Prostate Multiparametric MRI: Correlation With Whole-Mount Sectioning of Specimens. AJR Am J Roentgenol 211(4):783-788, 2018. e-Pub 2018. PMID: 30160988.
88. Wang X, Pirasteh A, Brugarolas J, Rofsky NM, Lenkinski RE, Pedrosa I, Madhuranthakam AJ. Whole-body MRI for metastatic cancer detection using T(2) -weighted imaging with fat and fluid suppression. Magn Reson Med 80(4):1402-1415, 2018. e-Pub 2018. PMID: 29446127.
89. Diaz de Leon A, Costa DN, Francis F, Pedrosa I. Case 258: Granulomatous Prostatitis. Radiology 289(1):267-271, 2018. e-Pub 2018. PMID: 30230997.
90. Wang T, Lu R, Kapur P, Jaiswal BS, Hannan R, Zhang Z, Pedrosa I, Luke JJ, Zhang H, Goldstein LD, Yousuf Q, Gu YF, McKenzie T, Joyce A, Kim MS, Wang X, Luo D, Onabolu O, Stevens C, Xie Z, Chen M, Filatenkov A, Torrealba J, Luo X, Guo W, He J, Stawiski E, Modrusan Z, Durinck S, Seshagiri S, Brugarolas J. An Empirical Approach Leveraging Tumorgrafts to Dissect the Tumor Microenvironment in Renal Cell Carcinoma Identifies Missing Link to Prognostic Inflammatory Factors. Cancer Discov 8(9):1142-1155, 2018. e-Pub 2018. PMID: 29884728.
91. Davenport MS, Chandarana H, Curci NE, Doshi A, Kaffenberger SD, Pedrosa I, Remer EM, Schieda N, Shinagare AB, Smith AD, Wang ZJ, Wells SA, Silverman SG. Society of Abdominal Radiology disease-focused panel on renal cell carcinoma: update on past, current, and future goals. Abdom Radiol (NY) 43(9):2213-2220, 2018. e-Pub 2018. PMID: 29948056.
92. Nelson DB, Khan A, Bailey A, Yokoo T, Pedrosa I, McIntire DD, Cunningham FG. Liver Injury in Hemolysis, Elevated Liver Enzymes, and Low Platelets Syndrome Measured by Diffusion-Weighted Magnetic Resonance Imaging. Am J Perinatol 35(8):741-747, 2018. e-Pub 2018. PMID: 29281843.
93. Xi Y, Liu A, Olumba F, Lawson P, Costa DN, Yuan Q, Khatri G, Yokoo T, Pedrosa I, Lenkinski RE. Low-to-high b value DWI ratio approaches in multiparametric MRI of the prostate: feasibility, optimal combination of b values, and comparison with ADC maps for the visual presentation of prostate cancer. Quant Imaging Med Surg 8(6):557-567, 2018. e-Pub 2018. PMID: 30140618.
94. Diaz de Leon A, Costa DN, Francis F, Pedrosa I. Case 258. Radiology 287(3):1070-1072, 2018. e-Pub 2018. PMID: 29782240.
95. Kay FU, Canvasser NE, Xi Y, Pinho DF, Costa DN, Diaz de Leon A, Khatri G, Leyendecker JR, Yokoo T, Lay AH, Kavoussi N, Koseoglu E, Cadeddu JA, Pedrosa I. Diagnostic Performance and Interreader Agreement of a Standardized MR Imaging Approach in the Prediction of Small Renal Mass Histology. Radiology 287(2):543-553, 2018. e-Pub 2018. PMID: 29390196.
96. Costa DN, Passoni NM, Leyendecker JR, de Leon AD, Lotan Y, Roehrborn CG, Otero-Muinelo S, Grewal H, Xi Y, Francis F, Rofsky NM, Pedrosa I. Diagnostic Utility of a Likert Scale Versus Qualitative Descriptors and Length of Capsular Contact for Determining Extraprostatic Tumor Extension at Multiparametric Prostate MRI. AJR Am J Roentgenol 210(5):1066-1072, 2018. e-Pub 2018. PMID: 29489410.
97. Greer JS, Maroules CD, Oz OK, Abbara S, Peshock RM, Pedrosa I, Madhuranthakam AJ. Non-contrast quantitative pulmonary perfusion using flow alternating inversion recovery at 3T: A preliminary study. Magn Reson Imaging 46:106-113, 2018. e-Pub 2018. PMID: 29154894.
98. Dwivedi DK, Chatzinoff Y, Zhang Y, Yuan Q, Fulkerson M, Chopra R, Brugarolas J, Cadeddu JA, Kapur P, Pedrosa I. Development of a Patient-specific Tumor Mold Using Magnetic Resonance Imaging and 3-Dimensional Printing Technology for Targeted Tissue Procurement and Radiomics Analysis of Renal Masses. Urology 112:209-214, 2018. e-Pub 2018. PMID: 29056576.
99. Clark H, Khatri G, Kapur P, Pedrosa I. Splenic Involvement in Disseminated Mycobacterium avium-intracellulare Infection: Magnetic Resonance Imaging Findings. J Comput Assist Tomogr 42(1):151-154, 2018. e-Pub 2018. PMID: 28708727.
100. Xi Y, Yuan Q, Zhang Y, Madhuranthakam AJ, Fulkerson M, Margulis V, Brugarolas J, Kapur P, Cadeddu JA, Pedrosa I. Statistical clustering of parametric maps from dynamic contrast enhanced MRI and an associated decision tree model for non-invasive tumour grading of T1b solid clear cell renal cell carcinoma. Eur Radiol 28(1):124-132, 2018. e-Pub 2018. PMID: 28681074.
101. Canvasser NE, Kay FU, Xi Y, Pinho DF, Costa D, de Leon AD, Khatri G, Leyendecker JR, Yokoo T, Lay A, Kavoussi N, Koseoglu E, Cadeddu JA, Pedrosa I. Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Identify Clear Cell Renal Cell Carcinoma in cT1a Renal Masses. J Urol 198(4):780-786, 2017. e-Pub 2017. PMID: 28457802.
102. Costa DN, Chatzinoff Y, Passoni NM, Kapur P, Roehrborn CG, Xi Y, Rofsky NM, Torrealba J, Francis F, Futch C, Hagens P, Notgrass H, Otero-Muinelo S, Pedrosa I, Chopra R. Improved Magnetic Resonance Imaging-Pathology Correlation With Imaging-Derived, 3D-Printed, Patient-Specific Whole-Mount Molds of the Prostate. Invest Radiol 52(9):507-513, 2017. e-Pub 2017. PMID: 28379863.
103. Zhang Y, Udayakumar D, Cai L, Hu Z, Kapur P, Kho EY, Pavia-Jimenez A, Fulkerson M, de Leon AD, Yuan Q, Dimitrov IE, Yokoo T, Ye J, Mitsche MA, Kim H, McDonald JG, Xi Y, Madhuranthakam AJ, Dwivedi DK, Lenkinski RE, Cadeddu JA, Margulis V, Brugarolas J, DeBerardinis RJ, Pedrosa I. Addressing metabolic heterogeneity in clear cell renal cell carcinoma with quantitative Dixon MRI. JCI Insight 2(15), 2017. e-Pub 2017. PMID: 28768909.
104. Gu YF, Cohn S, Christie A, McKenzie T, Wolff N, Do QN, Madhuranthakam AJ, Pedrosa I, Wang T, Dey A, Busslinger M, Xie XJ, Hammer RE, McKay RM, Kapur P, Brugarolas J. Modeling Renal Cell Carcinoma in Mice: Bap1 and Pbrm1 Inactivation Drive Tumor Grade. Cancer Discov 7(8):900-917, 2017. e-Pub 2017. PMID: 28473526.
105. Bowman IA, Pedrosa I, Kapur P, Brugarolas J. Renal Cell Carcinoma With Pulmonary Metastasis and Metachronous Non-Small Cell Lung Cancer. Clin Genitourin Cancer 15(4):e675-e680, 2017. e-Pub 2017. PMID: 28258962.
106. Costa DN, Kay FU, Pedrosa I, Kolski L, Lotan Y, Roehrborn CG, Hornberger B, Xi Y, Francis F, Rofsky NM. An initial negative round of targeted biopsies in men with highly suspicious multiparametric magnetic resonance findings does not exclude clinically significant prostate cancer-Preliminary experience. Urol Oncol 35(4):149.e15-149.e21, 2017. e-Pub 2017. PMID: 27939349.
107. Boos J, Brook A, Chingkoe CM, Morrison T, Mortele K, Raptopoulos V, Pedrosa I, Brook OR. MDCT vs. MRI for incidental pancreatic cysts: measurement variability and impact on clinical management. Abdom Radiol (NY) 42(2):521-530, 2017. e-Pub 2017. PMID: 27581431.
108. Ni Mhuircheartaigh JM, Lee KS, Curry MP, Pedrosa I, Mortele KJ. Early Peribiliary Hyperenhancement on MRI in Patients with Primary Sclerosing Cholangitis: Significance and Association with the Mayo Risk Score. Abdom Radiol (NY) 42(1):152-158, 2017. e-Pub 2017. PMID: 27472938.
109. Yokoo T, Patel AD, Lev-Cohain N, Singal AG, Yopp AC, Pedrosa I. Extrahepatic metastasis risk of hepatocellular carcinoma based on alpha-fetoprotein and tumor staging parameters at cross-sectional imaging. Cancer Manag Res 9:503-511, 2017. e-Pub 2017. PMID: 29081671.
110. Yuan Q, Kapur P, Zhang Y, Xi Y, Carvo I, Signoretti S, Dimitrov IE, Cadeddu JA, Margulis V, Brugarolas J, Madhuranthakam AJ, Pedrosa I. Intratumor Heterogeneity of Perfusion and Diffusion in Clear-Cell Renal Cell Carcinoma: Correlation With Tumor Cellularity. Clin Genitourin Cancer 14(6):e585-e594, 2016. e-Pub 2016. PMID: 27209349.
111. Chen W, Hill H, Christie A, Kim MS, Holloman E, Pavia-Jimenez A, Homayoun F, Ma Y, Patel N, Yell P, Hao G, Yousuf Q, Joyce A, Pedrosa I, Geiger H, Zhang H, Chang J, Gardner KH, Bruick RK, Reeves C, Hwang TH, Courtney K, Frenkel E, Sun X, Zojwalla N, Wong T, Rizzi JP, Wallace EM, Josey JA, Xie Y, Xie XJ, Kapur P, McKay RM, Brugarolas J. Targeting renal cell carcinoma with a HIF-2 antagonist. Nature 539(7627):112-117, 2016. e-Pub 2016. PMID: 27595394.
112. Pinho DF, Lev-Cohain N, Awdeh H, Xi Y, Khatri G, Yokoo T, Pedrosa I. Optimization of breathing instructions and timing of late arterial phase acquisition on gadobutrol-enhanced MRI of the liver. Clin Imaging 40(6):1274-1279, 2016. e-Pub 2016. PMID: 27684994.
113. Yokoo T, Clark HR, Pedrosa I, Yuan Q, Dimitrov I, Zhang Y, Lingvay I, Beg MS, Bobulescu IA. Quantification of renal steatosis in type II diabetes mellitus using dixon-based MRI. J Magn Reson Imaging 44(5):1312-1319, 2016. e-Pub 2016. PMID: 27007212.
114. Mariotti GC, Costa DN, Pedrosa I, Falsarella PM, Martins T, Roehrborn CG, Rofsky NM, Xi Y, M Andrade TC, Queiroz MR, Lotan Y, Garcia RG, Lemos GC, Baroni RH. Magnetic resonance/transrectal ultrasound fusion biopsy of the prostate compared to systematic 12-core biopsy for the diagnosis and characterization of prostate cancer: multi-institutional retrospective analysis of 389 patients. Urol Oncol 34(9):416.e9-416.e14, 2016. e-Pub 2016. PMID: 27197921.
115. Pirasteh A, Clark HR, Sorra EA 2nd, Pedrosa I, Yokoo T. Effect of steatosis on liver signal and enhancement on multiphasic contrast-enhanced magnetic resonance imaging. Abdom Radiol (NY) 41(9):1744-50, 2016. e-Pub 2016. PMID: 27108126.
116. Nofiele J, Yuan Q, Kazem M, Tatebe K, Torres Q, Sawant A, Pedrosa I, Chopra R. An MRI-compatible platform for one-dimensional motion management studies in MRI. Magn Reson Med 76(2):702-12, 2016. e-Pub 2016. PMID: 26493684.
117. Pirasteh A, VanDyke M, Bolton-Ronacher J, Xi Y, Eastland R, Young D, Escobar J, Hernandez C, Toomay S, Browning T, Pedrosa I. Implementation of an Online Screening and Check-In Process to Optimize Patient Workflow Before Outpatient MRI Studies. J Am Coll Radiol 13(8):956-959.e5, 2016. e-Pub 2016. PMID: 26786030.
118. Arai TJ, Nofiele J, Madhuranthakam AJ, Yuan Q, Pedrosa I, Chopra R, Sawant A. Characterizing spatiotemporal information loss in sparse-sampling-based dynamic MRI for monitoring respiration-induced tumor motion in radiotherapy. Med Phys 43(6):2807-2820, 2016. e-Pub 2016. PMID: 27277029.
119. Costa DN, Yuan Q, Xi Y, Rofsky NM, Lenkinski RE, Lotan Y, Roehrborn CG, Francis F, Travalini D, Pedrosa I. Comparison of prostate cancer detection at 3-T MRI with and without an endorectal coil: A prospective, paired-patient study. Urol Oncol 34(6):255.e7-255.e13, 2016. e-Pub 2016. PMID: 26971190.
120. Vanderheiden A, Harrison LB, Warshauer JT, Adams-Huet B, Li X, Yuan Q, Hulsey K, Dimitrov I, Yokoo T, Jaster AW, Pinho DF, Pedrosa I, Lenkinski RE, Pop LM, Lingvay I. Mechanisms of Action of Liraglutide in Patients With Type 2 Diabetes Treated With High-Dose Insulin. J Clin Endocrinol Metab 101(4):1798-806, 2016. e-Pub 2016. PMID: 26909799.
121. Sun MR, Brook A, Powell MF, Kaliannan K, Wagner AA, Kaplan ID, Pedrosa I. Effect of Stereotactic Body Radiotherapy on the Growth Kinetics and Enhancement Pattern of Primary Renal Tumors. AJR Am J Roentgenol 206(3):544-53, 2016. e-Pub 2016. PMID: 26901010.
122. Brook OR, Beddy P, Pahade J, Couto C, Brennan I, Patel P, Brook A, Pedrosa I. Delayed Growth in Incidental Pancreatic Cysts: Are the Current American College of Radiology Recommendations for Follow-up Appropriate?. Radiology 278(3):752-61, 2016. e-Pub 2016. PMID: 26348231.
123. Robson PM, Madhuranthakam AJ, Smith MP, Sun MR, Dai W, Rofsky NM, Pedrosa I, Alsop DC. Volumetric Arterial Spin-labeled Perfusion Imaging of the Kidneys with a Three-dimensional Fast Spin Echo Acquisition. Acad Radiol 23(2):144-54, 2016. e-Pub 2016. PMID: 26521186.
124. Zhang Y, Kapur P, Yuan Q, Xi Y, Carvo I, Signoretti S, Dimitrov I, Cadeddu JA, Margulis V, Muradyan N, Brugarolas J, Madhuranthakam AJ, Pedrosa I. Tumor Vascularity in Renal Masses: Correlation of Arterial Spin-Labeled and Dynamic Contrast-Enhanced Magnetic Resonance Imaging Assessments. Clin Genitourin Cancer 14(1):e25-36, 2016. e-Pub 2016. PMID: 26422014.
125. Onate Miranda M, Pinho DF, Wardak Z, Albuquerque K, Pedrosa I. Magnetic resonance imaging for planning intracavitary brachytherapy for the treatment of locally advanced cervical cancer. Radiologia 58(1):16-25, 2016. e-Pub 2016. PMID: 26545329.
126. Costa DN, Lotan Y, Rofsky NM, Roehrborn C, Liu A, Hornberger B, Xi Y, Francis F, Pedrosa I. Assessment of Prospectively Assigned Likert Scores for Targeted Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsies in Patients with Suspected Prostate Cancer. J Urol 195(1):80-7, 2016. e-Pub 2016. PMID: 26192254.
127. Yokoo T, Yuan Q, Senegas J, Wiethoff AJ, Pedrosa I. Quantitative R2* MRI of the liver with rician noise models for evaluation of hepatic iron overload: Simulation, phantom, and early clinical experience. J Magn Reson Imaging 42(6):1544-59, 2015. e-Pub 2015. PMID: 25996989.
128. Khatri G, Bailey AA, Bacsu C, Christie AL, Kumar N, Pedrosa I, Zimmern P. Influence of rectal gel volume on defecation during dynamic pelvic floor magnetic resonance imaging. Clin Imaging 39(6):1027-31, 2015. e-Pub 2015. PMID: 26253772.
129. Kim H, Rodriguez-Navas C, Kollipara RK, Kapur P, Pedrosa I, Brugarolas J, Kittler R, Ye J. Unsaturated Fatty Acids Stimulate Tumor Growth through Stabilization of beta-Catenin. Cell Rep 13(3):495-503, 2015. e-Pub 2015. PMID: 26456834.
130. Lotan Y, Haddad AQ, Costa DN, Pedrosa I, Rofsky NM, Roehrborn CG. Decision analysis model comparing cost of multiparametric magnetic resonance imaging vs. repeat biopsy for detection of prostate cancer in men with prior negative findings on biopsy. Urol Oncol 33(6):266.e9-16, 2015. e-Pub 2015. PMID: 25858102.
131. Brook OR, Brook A, Vollmer CM, Kent TS, Sanchez N, Pedrosa I. Structured reporting of multiphasic CT for pancreatic cancer: potential effect on staging and surgical planning. Radiology 274(2):464-72, 2015. e-Pub 2015. PMID: 25286323.
132. Durinck S, Stawiski EW, Pavia-Jimenez A, Modrusan Z, Kapur P, Jaiswal BS, Zhang N, Toffessi-Tcheuyap V, Nguyen TT, Pahuja KB, Chen YJ, Saleem S, Chaudhuri S, Heldens S, Jackson M, Pena-Llopis S, Guillory J, Toy K, Ha C, Harris CJ, Holloman E, Hill HM, Stinson J, Rivers CS, Janakiraman V, Wang W, Kinch LN, Grishin NV, Haverty PM, Chow B, Gehring JS, Reeder J, Pau G, Wu TD, Margulis V, Lotan Y, Sagalowsky A, Pedrosa I, de Sauvage FJ, Brugarolas J, Seshagiri S. Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes. Nat Genet 47(1):13-21, 2015. e-Pub 2015. PMID: 25401301.
133. Hannan R, Margulis V, Chun SG, Cannon N, Kim DW, Abdulrahman RE, Sagalowsky A, Pedrosa I, Choy H, Brugarolas J, Timmerman RD. Stereotactic radiation therapy of renal cancer inferior vena cava tumor thrombus. Cancer Biol Ther 16(5):657-61, 2015. e-Pub 2015. PMID: 25800036.
134. Wang SS, Gu YF, Wolff N, Stefanius K, Christie A, Dey A, Hammer RE, Xie XJ, Rakheja D, Pedrosa I, Carroll T, McKay RM, Kapur P, Brugarolas J. Bap1 is essential for kidney function and cooperates with Vhl in renal tumorigenesis. Proc Natl Acad Sci U S A 111(46):16538-43, 2014. e-Pub 2014. PMID: 25359211.
135. Donato F Jr, Costa DN, Yuan Q, Rofsky NM, Lenkinski RE, Pedrosa I. Geometric distortion in diffusion-weighted MR imaging of the prostate-contributing factors and strategies for improvement. Acad Radiol 21(6):817-23, 2014. e-Pub 2014. PMID: 24709379.
136. Madhuranthakam AJ, Lee KS, Yassin A, Brittain JH, Pedrosa I, Rofsky NM, Alsop DC. Improved short tau inversion recovery (iSTIR) for increased tumor conspicuity in the abdomen. MAGMA 27(3):245-55, 2014. e-Pub 2014. PMID: 24052241.
137. Beddy P, Genega EM, Ngo L, Hindman N, Wei J, Bullock A, Bhatt RS, Atkins MB, Pedrosa I. Tumor necrosis on magnetic resonance imaging correlates with aggressive histology and disease progression in clear cell renal cell carcinoma. Clin Genitourin Cancer 12(1):55-62, 2014. e-Pub 2014. PMID: 24145001.
138. Straka C, Kim DW, Timmerman RD, Pedrosa I, Jacobs C, Brugarolas J. Ablation of a site of progression with stereotactic body radiation therapy extends sunitinib treatment from 14 to 22 months. J Clin Oncol 31(23):e401-3, 2013. e-Pub 2013. PMID: 23796996.
139. Costa DN, Bloch BN, Yao DF, Sanda MG, Ngo L, Genega EM, Pedrosa I, DeWolf WC, Rofsky NM. Diagnosis of relevant prostate cancer using supplementary cores from magnetic resonance imaging-prompted areas following multiple failed biopsies. Magn Reson Imaging 31(6):947-52, 2013. e-Pub 2013. PMID: 23602725.
140. Rosenkrantz AB, Sekhar A, Genega EM, Melamed J, Babb JS, Patel AD, Lo A, Najarian RM, Ahmed M, Pedrosa I. Prognostic implications of the magnetic resonance imaging appearance in papillary renal cell carcinoma. Eur Radiol 23(2):579-87, 2013. e-Pub 2013. PMID: 22903703.
141. Lev-Cohain N, Kapur P, Pedrosa I. Vulvar fibroadenoma with lactational changes in ectopic breast tissue. Case Rep Obstet Gynecol 2013:924902, 2013. e-Pub 2013. PMID: 24222874.
142. Lanzman RS, Robson PM, Sun MR, Patel AD, Mentore K, Wagner AA, Genega EM, Rofsky NM, Alsop DC, Pedrosa I. Arterial spin-labeling MR imaging of renal masses: correlation with histopathologic findings. Radiology 265(3):799-808, 2012. e-Pub 2012. PMID: 23047841.
143. Yassin A, Pedrosa I, Kearney M, Genega E, Rofsky NM, Lenkinski RE. In vitro MR imaging of renal stones with an ultra-short echo time magnetic resonance imaging sequence. Acad Radiol 19(12):1566-72, 2012. e-Pub 2012. PMID: 22959582.
144. Hindman N, Ngo L, Genega EM, Melamed J, Wei J, Braza JM, Rofsky NM, Pedrosa I. Angiomyolipoma with minimal fat: can it be differentiated from clear cell renal cell carcinoma by using standard MR techniques?. Radiology 265(2):468-77, 2012. e-Pub 2012. PMID: 23012463.
145. Bloch BN, Genega EM, Costa DN, Pedrosa I, Smith MP, Kressel HY, Ngo L, Sanda MG, Dewolf WC, Rofsky NM. Prediction of prostate cancer extracapsular extension with high spatial resolution dynamic contrast-enhanced 3-T MRI. Eur Radiol 22(10):2201-10, 2012. e-Pub 2012. PMID: 22661019.
146. Dabydeen DA, Jagannathan JP, Ramaiya N, Krajewski K, Schutz FA, Cho DC, Pedrosa I, Choueiri TK. Pneumonitis associated with mTOR inhibitors therapy in patients with metastatic renal cell carcinoma: incidence, radiographic findings and correlation with clinical outcome. Eur J Cancer 48(10):1519-24, 2012. e-Pub 2012. PMID: 22483544.
147. Nadig SN, Pedrosa I, Goldsmith JD, Callery MP, Vollmer CM. Clinical implications of mucinous nonneoplastic cysts of the pancreas. Pancreas 41(3):441-6, 2012. e-Pub 2012. PMID: 22015974.
148. Sun MR, Wagner AA, San Francisco IF, Brook A, Kavoussi L, Russo P, Steele G, Viterbo R, Pedrosa I. Need for intraoperative ultrasound and surgical recommendation for partial nephrectomy: correlation with tumor imaging features and urologist practice patterns. Ultrasound Q 28(1):21-7, 2012. e-Pub 2012. PMID: 22357225.
149. Lee KS, Munoz A, Baez AB, Ngo L, Rofsky NM, Pedrosa I. Corticomedullary differentiation on T1-Weighted MRI: comparison between cirrhotic and noncirrhotic patients. J Magn Reson Imaging 35(3):644-9, 2012. e-Pub 2012. PMID: 22031466.
150. Torres VE, Chapman AB, Perrone RD, Bae KT, Abebe KZ, Bost JE, Miskulin DC, Steinman TI, Braun WE, Winklhofer FT, Hogan MC, Oskoui FR, Kelleher C, Masoumi A, Glockner J, Halin NJ, Martin DR, Remer E, Patel N, Pedrosa I, Wetzel LH, Thompson PA, Miller JP, Meyers CM, Schrier RW. Analysis of baseline parameters in the HALT polycystic kidney disease trials. Kidney Int 81(6):577-85, 2012. e-Pub 2012. PMID: 22205355.
151. Pedrosa I, Rafatzand K, Robson P, Wagner AA, Atkins MB, Rofsky NM, Alsop DC. Arterial spin labeling MR imaging for characterisation of renal masses in patients with impaired renal function: initial experience. Eur Radiol 22(2):484-92, 2012. e-Pub 2012. PMID: 21877173.
152. Keeling AN, Morrin MM, McKenzie C, Farrell RJ, Sheth SG, Ngo L, Bloch BN, Pedrosa I, Rofsky NM. Intravenous, contrast-enhanced MR colonography using air as endoluminal contrast agent: impact on colorectal polyp detection. Eur J Radiol 81(1):31-8, 2012. e-Pub 2012. PMID: 21131152.
153. Perrone RD, Abebe KZ, Schrier RW, Chapman AB, Torres VE, Bost J, Kaya D, Miskulin DC, Steinman TI, Braun W, Winklhofer FT, Hogan MC, Rahbari-Oskoui F, Kelleher C, Masoumi A, Glockner J, Halin NJ, Martin D, Remer E, Patel N, Pedrosa I, Wetzel LH, Thompson PA, Miller JP, Bae KT, Meyers CM. Cardiac magnetic resonance assessment of left ventricular mass in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 6(10):2508-15, 2011. e-Pub 2011. PMID: 21903983.
154. Pahade JK, LeBedis CA, Raptopoulos VD, Avigan DE, Yam CS, Kruskal JB, Pedrosa I. Incidence of contrast-induced nephropathy in patients with multiple myeloma undergoing contrast-enhanced CT. AJR Am J Roentgenol 196(5):1094-101, 2011. e-Pub 2011. PMID: 21512075.
155. Krajewski KM, Guo M, Van den Abbeele AD, Yap J, Ramaiya N, Jagannathan J, Heng DY, Atkins MB, McDermott DF, Schutz FA, Pedrosa I, Choueiri TK. Comparison of four early posttherapy imaging changes (EPTIC; RECIST 1.0, tumor shrinkage, computed tomography tumor density, Choi criteria) in assessing outcome to vascular endothelial growth factor-targeted therapy in patients with advanced renal cell carcinoma. Eur Urol 59(5):856-62, 2011. e-Pub 2011. PMID: 21306819.
156. Pedrosa I, Boparai D. Imaging considerations in intraductal papillary mucinous neoplasms of the pancreas. World J Gastrointest Surg 2(10):324-30, 2010. e-Pub 2010. PMID: 21160838.
157. Lee KS, Sekhar A, Rofsky NM, Pedrosa I. Prevalence of incidental pancreatic cysts in the adult population on MR imaging. Am J Gastroenterol 105(9):2079-84, 2010. e-Pub 2010. PMID: 20354507.
158. Sena BF, Stern JP, Pandharipande PV, Klemm B, Bulman J, Pedrosa I, Rofsky NM. Screening patients to assess renal function before administering gadolinium chelates: assessment of the Choyke questionnaire. AJR Am J Roentgenol 195(2):424-8, 2010. e-Pub 2010. PMID: 20651199.
159. Hong SN, Rahimi A, Kissinger KV, Pedrosa I, Manning WJ, O'Halloran TD. Cardiac magnetic resonance imaging and the WATCHMAN device. J Am Coll Cardiol 55(24):2785, 2010. e-Pub 2010. PMID: 20538174.
160. Kung JW, Brown A, Kruskal JB, Goldsmith JD, Pedrosa I. Heterotopic pancreas: typical and atypical imaging findings. Clin Radiol 65(5):403-7, 2010. e-Pub 2010. PMID: 20380941.
161. Lee KS, Zeikus E, DeWolf WC, Rofsky NM, Pedrosa I. MR urography versus retrograde pyelography/ureteroscopy for the exclusion of upper urinary tract malignancy. Clin Radiol 65(3):185-92, 2010. e-Pub 2010. PMID: 20152273.
162. McMahon CJ, Vollmer CM Jr, Goldsmith J, Brown A, Pleskow D, Pedrosa I. An unusual variant of anomalous pancreaticobiliary junction in a patient with pancreas divisum diagnosed with secretin-magnetic resonance cholangiopancreatography. Pancreas 39(1):101-4, 2010. e-Pub 2010. PMID: 20019565.
163. Asch E, Levine D, Pedrosa I, Hecht JL, Kruskal J. Patterns of misinterpretation of adnexal masses on CT and MR in an academic radiology department. Acad Radiol 16(8):969-80, 2009. e-Pub 2009. PMID: 19380241.
164. Pedrosa I, Ngo L, Wei J, Schuster M, Mahallati H, Smith M, Rofsky NM. Dynamic half-Fourier single-shot turbo spin echo for assessment of deep venous thrombosis: initial observations. Magn Reson Imaging 27(5):617-24, 2009. e-Pub 2009. PMID: 19106024.
165. Robson PM, Madhuranthakam AJ, Dai W, Pedrosa I, Rofsky NM, Alsop DC. Strategies for reducing respiratory motion artifacts in renal perfusion imaging with arterial spin labeling. Magn Reson Med 61(6):1374-87, 2009. e-Pub 2009. PMID: 19319891.
166. Schor-Bardach R, Alsop DC, Pedrosa I, Solazzo SA, Wang X, Marquis RP, Atkins MB, Regan M, Signoretti S, Lenkinski RE, Goldberg SN. Does arterial spin-labeling MR imaging-measured tumor perfusion correlate with renal cell cancer response to antiangiogenic therapy in a mouse model?. Radiology 251(3):731-42, 2009. e-Pub 2009. PMID: 19474376.
167. Atkins MB, Bukowski RM, Escudier BJ, Figlin RA, Hudes GH, Kaelin WG Jr, Linehan WM, McDermott DF, Mier JW, Pedrosa I, Rini BI, Signoretti S, Sosman JA, Teh BT, Wood CG, Zurita AJ, King L. Innovations and challenges in renal cancer: summary statement from the Third Cambridge Conference. Cancer 115(10 Suppl):2247-51, 2009. e-Pub 2009. PMID: 19402064.
168. Sun MR, Ngo L, Genega EM, Atkins MB, Finn ME, Rofsky NM, Pedrosa I. Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings. Radiology 250(3):793-802, 2009. e-Pub 2009. PMID: 19244046.
169. Vadnais M, Awtrey C, Pedrosa I. Breaking point: magnetic resonance imaging evaluation of an obstetric emergency. Am J Obstet Gynecol 200(3):344.e1-3, 2009. e-Pub 2009. PMID: 18992862.
170. Pedrosa I, Lafornara M, Pandharipande PV, Goldsmith JD, Rofsky NM. Pregnant patients suspected of having acute appendicitis: effect of MR imaging on negative laparotomy rate and appendiceal perforation rate. Radiology 250(3):749-57, 2009. e-Pub 2009. PMID: 19244044.
171. Ganguli S, Camacho M, Yam CS, Pedrosa I. Preparing first-year radiology residents and assessing their readiness for on-call responsibilities: results over 5 years. AJR Am J Roentgenol 192(2):539-44, 2009. e-Pub 2009. PMID: 19155422.
172. Lee KS, Rofsky NM, Pedrosa I. Localization of the appendix at MR imaging during pregnancy: utility of the cecal tilt angle. Radiology 249(1):134-41, 2008. e-Pub 2008. PMID: 18710961.
173. de Bazelaire C, Alsop DC, George D, Pedrosa I, Wang Y, Michaelson MD, Rofsky NM. Magnetic resonance imaging-measured blood flow change after antiangiogenic therapy with PTK787/ZK 222584 correlates with clinical outcome in metastatic renal cell carcinoma. Clin Cancer Res 14(17):5548-54, 2008. e-Pub 2008. PMID: 18765547.
174. Morrin MM, Pedrosa I, McKenzie CA, Farrell RJ, Bloch N, Solazzo S, Ngo L, Goldberg SN, Rofsky NM. Parallel imaging enhanced MR colonography using a phantom model. J Magn Reson Imaging 28(3):664-72, 2008. e-Pub 2008. PMID: 18777549.
175. Ganguli S, Pedrosa I, Smith MP, Niendorf ER, Fredericks S, Rofsky NM. Low dose pedal magnetic resonance angiography at 3 tesla with time-resolved imaging of contrast kinetics: a feasibility study. Invest Radiol 43(9):650-5, 2008. e-Pub 2008. PMID: 18708859.
176. Pedrosa I, Chou MT, Ngo L, H Baroni R, Genega EM, Galaburda L, DeWolf WC, Rofsky NM. MR classification of renal masses with pathologic correlation. Eur Radiol 18(2):365-75, 2008. e-Pub 2008. PMID: 17899106.
177. Adey GS, Pedrosa I, Rofsky NM, Sanda MG, DeWolf WC. Lower limits of detection using magnetic resonance imaging for solid components in cystic renal neoplasms. Urology 71(1):47-51, 2008. e-Pub 2008. PMID: 18242363.
178. Pedrosa I, Zeikus EA, Levine D, Rofsky NM. MR imaging of acute right lower quadrant pain in pregnant and nonpregnant patients. Radiographics 27(3):721-43; discussion 743-53, 2007. e-Pub 2007. PMID: 17495289.
179. Raptopoulos VD, Boiselle PB, Michailidis N, Handwerker J, Sabir A, Edlow JA, Pedrosa I, Kruskal JB. MDCT angiography of acute chest pain: evaluation of ECG-gated and nongated techniques. AJR Am J Roentgenol 186(6 Suppl 2):S346-56, 2006. e-Pub 2006. PMID: 16714608.
180. Yam CS, Kruskal J, Pedrosa I, Kressel H. Part II: preparing and assessing first-year radiology resident on-call readiness technical implementation. Acad Radiol 13(6):770-3, 2006. e-Pub 2006. PMID: 16679281.
181. Ganguli S, Pedrosa I, Yam CS, Appignani B, Siewert B, Kressel HY. Part I: preparing first-year radiology residents and assessing their readiness for on-call responsibilities. Acad Radiol 13(6):764-9, 2006. e-Pub 2006. PMID: 16679280.
182. Sanchez LD, Tracy JA, Berkoff D, Pedrosa I. Ischemic colitis in marathon runners: a case-based review. J Emerg Med 30(3):321-6, 2006. e-Pub 2006. PMID: 16677987.
183. Pedrosa I, Levine D, Eyvazzadeh AD, Siewert B, Ngo L, Rofsky NM. MR imaging evaluation of acute appendicitis in pregnancy. Radiology 238(3):891-9, 2006. e-Pub 2006. PMID: 16505393.
184. Pedrosa I, Morrin M, Oleaga L, Baptista J, Rofsky NM. Is true FISP imaging reliable in the evaluation of venous thrombosis?. AJR Am J Roentgenol 185(6):1632-40, 2005. e-Pub 2005. PMID: 16304026.
185. Brennan D, Pedrosa I. Lymphoplasmacytic sclerosing pancreatitis. AJR Am J Roentgenol 185(5):1367-8; author reply 1368, 2005. e-Pub 2005. PMID: 16247168.
186. Johnson TR, Pedrosa I, Goldsmith J, Dewolf WC, Rofsky NM. Magnetic resonance imaging findings in solitary fibrous tumor of the kidney. J Comput Assist Tomogr 29(4):481-3, 2005. e-Pub 2005. PMID: 16012305.
187. Katz-Brull R, Rofsky NM, Morrin MM, Pedrosa I, George DJ, Michaelson MD, Marquis RP, Maril M, Noguera C, Lenkinski RE. Decreases in free cholesterol and fatty acid unsaturation in renal cell carcinoma demonstrated by breath-hold magnetic resonance spectroscopy. Am J Physiol Renal Physiol 288(4):F637-41, 2005. e-Pub 2005. PMID: 15572523.
188. Niendorf T, Saranathan M, Lingamneni A, Pedrosa I, Spencer M, Cline H, Foo TK, Rofsky NM. Short breath-hold, volumetric coronary MR angiography employing steady-state free precession in conjunction with parallel imaging. Magn Reson Med 53(4):885-94, 2005. e-Pub 2005. PMID: 15799036.
189. Baroni RH, Pedrosa I, Tavernaraki E, Goldsmith J, Rofsky NM. Pancreatic sarcoidosis: MRI features. J Magn Reson Imaging 20(5):889-93, 2004. e-Pub 2004. PMID: 15503350.
190. Eyvazzadeh AD, Pedrosa I, Rofsky NM, Siewert B, Farrar N, Abbott J, Levine D. MRI of right-sided abdominal pain in pregnancy. AJR Am J Roentgenol 183(4):907-14, 2004. e-Pub 2004. PMID: 15385280.
191. Sosna J, Pedrosa I, Dewolf WC, Mahallati H, Lenkinski RE, Rofsky NM. MR imaging of the prostate at 3 Tesla: comparison of an external phased-array coil to imaging with an endorectal coil at 1.5 Tesla. Acad Radiol 11(8):857-62, 2004. e-Pub 2004. PMID: 15354305.
192. Bloch BN, Rofsky NM, Baroni RH, Marquis RP, Pedrosa I, Lenkinski RE. 3 Tesla magnetic resonance imaging of the prostate with combined pelvic phased-array and endorectal coils; Initial experience(1). Acad Radiol 11(8):863-7, 2004. e-Pub 2004. PMID: 15288036.
193. Weber A, Pedrosa I, Kawamoto A, Himes N, Munasinghe J, Asahara T, Rofsky NM, Losordo DW. Magnetic resonance mapping of transplanted endothelial progenitor cells for therapeutic neovascularization in ischemic heart disease. Eur J Cardiothorac Surg 26(1):137-43, 2004. e-Pub 2004. PMID: 15200992.
194. McKenzie CA, Lim D, Ransil BJ, Morrin M, Pedrosa I, Yeh EN, Sodickson DK, Rofsky NM. Shortening MR image acquisition time for volumetric interpolated breath-hold examination with a recently developed parallel imaging reconstruction technique: clinical feasibility. Radiology 230(2):589-94, 2004. e-Pub 2004. PMID: 14699184.
195. Pedrosa I, Guarise A, Goldsmith J, Procacci C, Rofsky NM. The interrupted rim sign in acute cholecystitis: a method to identify the gangrenous form with MRI. J Magn Reson Imaging 18(3):360-3, 2003. e-Pub 2003. PMID: 12938133.
196. Pedrosa I, Aschkenasi C, Hamdan A, Rofsky NM. Effort-induced thrombosis: diagnosis with three-dimensional MR venography. Emerg Radiol 9(6):326-8, 2002. e-Pub 2002. PMID: 15290545.
197. Pedrosa I, Jorquera M, Mendez R, Cabeza B. Cervical spine fractures in ankylosing spondylitis: MR findings. Emerg Radiol 9(1):38-42, 2002. e-Pub 2002. PMID: 15290599.
198. Pedrosa I, Naidich JJ, Rofsky NM, Bosniak MA. Renal pseudotumors due to fat necrosis in acute pancreatitis. J Comput Assist Tomogr 25(2):236-8, 2001. e-Pub 2001. PMID: 11242220.
199. Macari M, Lavelle M, Pedrosa I, Milano A, Dicker M, Megibow AJ, Xue X. Effect of different bowel preparations on residual fluid at CT colonography. Radiology 218(1):274-7, 2001. e-Pub 2001. PMID: 11152814.
200. Arrazola J, Pedrosa I, Mendez R, Saldana C, Scheithauer BW, Martinez A. Primary malignant rhabdoid tumour of the brain in an adult. Neuroradiology 42(5):363-7, 2000. e-Pub 2000. PMID: 10872158.
201. Merino S, Saiz A, Moreno MJ, Parlorio E, Pedrosa I, Yus M. CT evaluation of gastric wall pathology. Br J Radiol 72(863):1124-31, 1999. e-Pub 1999. PMID: 10700834.
202. Parlorio E, Arrazola J, Pedrosa I, Ruiz MA. Primitive neuroectodermal tumor of the kidney. AJR Am J Roentgenol 171(5):1432-3, 1998. e-Pub 1998. PMID: 9798901.

Review Articles

1. Su, S, Yadu, N, Khatri, G, Khasawneh, H, Pedrosa, I, Yokoo, T. An algorithmic approach to MR characterization of focal liver lesions in adults without cirrhosis. European Journal of Radiology 185, 2025. e-Pub 2025. PMID: 39978238.
2. Pedrosa I, Altman DA, Dillman JR, Hoff MN, McKinney AM, Reeder SB, Rogg JM, Stafford RJ, Webb JA, Hernandez DL, Watson RE. American College of Radiology Manual on MR Safety: 2024 Update and Revisions. Radiology 315(1):e241405, 2025. e-Pub 2025. PMID: 40167436.
3. Silverman, SG, Pedrosa, I, Schieda, N, Margulis, V, Kapur, P, Davenport, MS. In Pursuit of KI-RADS. Radiology 314(3), 2025. e-Pub 2025. PMID: 40100027.
4. Costa DN, Nguyen N, Garant A, Meng X, Courtney KD, Shah RB, Pedrosa I. The role of the radiologist in the prostate cancer multidisciplinary conference. Abdom Radiol (NY) 49(11):4162-4172, 2024. e-Pub 2024. PMID: 38951230.
5. Vinogradov, E, Keupp, J, Dimitrov, IE, Seiler, S, Pedrosa, I. CEST-MRI for body oncologic imaging. NMR in Biomedicine 36(6), 2023. e-Pub 2023. PMID: 36640112.
6. Roussel E, Capitanio U, Kutikov A, Oosterwijk E, Pedrosa I, Rowe SP, Gorin MA. Novel Imaging Methods for Renal Mass Characterization: A Collaborative Review. Eur Urol 81(5):476-488, 2022. e-Pub 2022. PMID: 35216855.
7. Roussel E, Campi R, Amparore D, Bertolo R, Carbonara U, Erdem S, Ingels A, Kara O, Marandino L, Marchioni M, Muselaers S, Pavan N, Pecoraro A, Beuselinck B, Pedrosa I, Fetzer D, Albersen M, On Behalf Of The European Association Of Urology Eau Young Academic Urologists Yau Renal Cancer Working Group. Expanding the Role of Ultrasound for the Characterization of Renal Masses. J Clin Med 11(4), 2022. e-Pub 2022. PMID: 35207384.
8. Pedrosa I, Cadeddu JA. How We Do It: Managing the Indeterminate Renal Mass with the MRI Clear Cell Likelihood Score. Radiology 302(2):256-269, 2022. e-Pub 2022. PMID: 34904873.
9. Schieda N, Krishna S, Pedrosa I, Kaffenberger SD, Davenport MS, Silverman SG. Active Surveillance of Renal Masses: The Role of Radiology. Radiology 302(1):11-24, 2022. e-Pub 2022. PMID: 34812670.
10. Krishna S, Schieda N, Pedrosa I, Hindman N, Baroni RH, Silverman SG, Davenport MS. Update on MRI of Cystic Renal Masses Including Bosniak Version 2019. J Magn Reson Imaging 54(2):341-356, 2021. e-Pub 2021. PMID: 33009722.
11. Pirasteh A, Lovrec P, Pedrosa I. Imaging and its Impact on Defining the Oligometastatic State. Semin Radiat Oncol 31(3):186-199, 2021. e-Pub 2021. PMID: 34090645.
12. Edney E, Davenport MS, Curci N, Schieda N, Krishna S, Hindman N, Silverman SG, Pedrosa I. Bosniak classification of cystic renal masses, version 2019: interpretation pitfalls and recommendations to avoid misclassification. Abdom Radiol (NY) 46(6):2699-2711, 2021. e-Pub 2021. PMID: 33484283.
13. Venkataraman V, Browning T, Pedrosa I, Abbara S, Fetzer D, Toomay S, Peshock RM. Implementing Shared, Standardized Imaging Protocols to Improve Cross-Enterprise Workflow and Quality. J Digit Imaging 32(5):880-887, 2019. e-Pub 2019. PMID: 30756266.
14. Silverman SG, Pedrosa I, Ellis JH, Hindman NM, Schieda N, Smith AD, Remer EM, Shinagare AB, Curci NE, Raman SS, Wells SA, Kaffenberger SD, Wang ZJ, Chandarana H, Davenport MS. Bosniak Classification of Cystic Renal Masses, Version 2019: An Update Proposal and Needs Assessment. Radiology 292(2):475-488, 2019. e-Pub 2019. PMID: 31210616.
15. Diaz de Leon A, Pirasteh A, Costa DN, Kapur P, Hammers H, Brugarolas J, Pedrosa I. Current Challenges in Diagnosis and Assessment of the Response of Locally Advanced and Metastatic Renal Cell Carcinoma. Radiographics 39(4):998-1016, 2019. e-Pub 2019. PMID: 31199711.
16. Diaz de Leon A, Davenport MS, Silverman SG, Schieda N, Cadeddu JA, Pedrosa I. Role of Virtual Biopsy in the Management of Renal Masses. AJR Am J Roentgenol 212(6):1234-1243, 2019. e-Pub 2019. PMID: 30995092.
17. Canellas R, Rosenkrantz AB, Taouli B, Sala E, Saini S, Pedrosa I, Wang ZJ, Sahani DV. Abbreviated MRI Protocols for the Abdomen. Radiographics 39(3):744-758, 2019. e-Pub 2019. PMID: 30901285.
18. de Leon AD, Kapur P, Pedrosa I. Radiomics in Kidney Cancer: MR Imaging. Magn Reson Imaging Clin N Am 27(1):1-13, 2019. e-Pub 2019. PMID: 30466904.
19. Krajewski KM, Pedrosa I. Imaging Advances in the Management of Kidney Cancer. J Clin Oncol 36(36):JCO2018791236, 2018. e-Pub 2018. PMID: 30372386.
20. Kay FU, Pedrosa I. Imaging of Solid Renal Masses. Urol Clin North Am 45(3):311-330, 2018. e-Pub 2018. PMID: 30031457.
21. Madhuranthakam AJ, Yuan Q, Pedrosa I. Quantitative Methods in Abdominal MRI: Perfusion Imaging. Top Magn Reson Imaging 26(6):251-258, 2017. e-Pub 2017. PMID: 29176470.
22. Diaz de Leon A, Pedrosa I. Imaging and Screening of Kidney Cancer. Radiol Clin North Am 55(6):1235-1250, 2017. e-Pub 2017. PMID: 28991563.
23. Gonzalez-Fernandez S, Fernandez-Rodriguez C, Mota-Alonso MJ, Garcia-Teijido P, Pedrosa I, Perez-Alvarez M. Emotional state and psychological flexibility in breast cancer survivors. Eur J Oncol Nurs 30:75-83, 2017. e-Pub 2017. PMID: 29031317.
24. Gupta MK, Khatri G, Bailey A, Pinho DF, Costa D, Pedrosa I. Endoluminal contrast for abdomen and pelvis magnetic resonance imaging. Abdom Radiol (NY) 41(7):1378-98, 2016. e-Pub 2016. PMID: 26907710.
25. Khatri G, Carmel ME, Bailey AA, Foreman MR, Brewington CC, Zimmern PE, Pedrosa I. Postoperative Imaging after Surgical Repair for Pelvic Floor Dysfunction. Radiographics 36(4):1233-56, 2016. e-Pub 2016. PMID: 27399245.
26. Diaz de Leon A, Costa D, Pedrosa I. Role of Multiparametric MR Imaging in Malignancies of the Urogenital Tract. Magn Reson Imaging Clin N Am 24(1):187-204, 2016. e-Pub 2016. PMID: 26613881.
27. Costa DN, Pedrosa I, Donato F Jr, Roehrborn CG, Rofsky NM. MR Imaging-Transrectal US Fusion for Targeted Prostate Biopsies: Implications for Diagnosis and Clinical Management. Radiographics 35(3):696-708, 2015. e-Pub 2015. PMID: 25786055.
28. Furey EA, Bailey AA, Pedrosa I. Magnetic resonance imaging of acute abdominal and pelvic pain in pregnancy. Top Magn Reson Imaging 23(4):225-42, 2014. e-Pub 2014. PMID: 25099561.
29. Costa DN, Pedrosa I, Roehrborn C, Rofsky NM. Multiparametric magnetic resonance imaging of the prostate: technical aspects and role in clinical management. Top Magn Reson Imaging 23(4):243-57, 2014. e-Pub 2014. PMID: 25099562.
30. Moore WA, Khatri G, Madhuranthakam AJ, Sims RD, Pedrosa I. Added value of diffusion-weighted acquisitions in MRI of the abdomen and pelvis. AJR Am J Roentgenol 202(5):995-1006, 2014. e-Pub 2014. PMID: 24758652.
31. Campbell N, Rosenkrantz AB, Pedrosa I. MRI phenotype in renal cancer: is it clinically relevant?. Top Magn Reson Imaging 23(2):95-115, 2014. e-Pub 2014. PMID: 24690616.
32. Pinho DF, Rofsky NM, Pedrosa I. Incidental pancreatic cysts: role of magnetic resonance imaging. Top Magn Reson Imaging 23(2):117-28, 2014. e-Pub 2014. PMID: 24690615.
33. Dewhurst C, Beddy P, Pedrosa I. MRI evaluation of acute appendicitis in pregnancy. J Magn Reson Imaging 37(3):566-75, 2013. e-Pub 2013. PMID: 23423797.
34. Katabathina VS, Lassau N, Pedrosa I, Ng CS, Prasad SR. Evaluation of treatment response in patients with metastatic renal cell carcinoma: role of state-of-the-art cross-sectional imaging. Curr Urol Rep 13(1):70-81, 2012. e-Pub 2012. PMID: 22143974.
35. Krajewski KM, Giardino AA, Zukotynski K, Van den Abbeele AD, Pedrosa I. Imaging in renal cell carcinoma. Hematol Oncol Clin North Am 25(4):687-715, 2011. e-Pub 2011. PMID: 21763963.
36. McMahon CJ, Rofsky NM, Pedrosa I. Lymphatic metastases from pelvic tumors: anatomic classification, characterization, and staging. Radiology 254(1):31-46, 2010. e-Pub 2010. PMID: 20032141.
37. Sun MR, Pedrosa I. Magnetic resonance imaging of renal masses. Semin Ultrasound CT MR 30(4):326-51, 2009. e-Pub 2009. PMID: 19711644.
38. Pedrosa I, Alsop DC, Rofsky NM. Magnetic resonance imaging as a biomarker in renal cell carcinoma. Cancer 115(10 Suppl):2334-45, 2009. e-Pub 2009. PMID: 19402070.
39. Pahade JK, Litmanovich D, Pedrosa I, Romero J, Bankier AA, Boiselle PM. Quality initiatives: imaging pregnant patients with suspected pulmonary embolism: what the radiologist needs to know. Radiographics 29(3):639-54, 2009. e-Pub 2009. PMID: 19270072.
40. Pedrosa I, Sun MR, Spencer M, Genega EM, Olumi AF, Dewolf WC, Rofsky NM. MR imaging of renal masses: correlation with findings at surgery and pathologic analysis. Radiographics 28(4):985-1003, 2008. e-Pub 2008. PMID: 18635625.
41. Zamboni GA, Pedrosa I, Kruskal JB, Raptopoulos V. Multimodality postoperative imaging of liver transplantation. Eur Radiol 18(5):882-91, 2008. e-Pub 2008. PMID: 18175119.
42. Costa DN, Pedrosa I, McKenzie C, Reeder SB, Rofsky NM. Body MRI using IDEAL. AJR Am J Roentgenol 190(4):1076-84, 2008. e-Pub 2008. PMID: 18356458.
43. Scaglione M, Pinto A, Pedrosa I, Sparano A, Romano L. Multi-detector row computed tomography and blunt chest trauma. Eur J Radiol 65(3):377-88, 2008. e-Pub 2008. PMID: 17954019.
44. Barth MM, Smith MP, Pedrosa I, Lenkinski RE, Rofsky NM. Body MR imaging at 3.0 T: understanding the opportunities and challenges. Radiographics 27(5):1445-62; discussion 1462-4, 2007. e-Pub 2007. PMID: 17848702.
45. Pedrosa I, Rofsky NM. MR imaging in abdominal emergencies. Radiol Clin North Am 41(6):1243-73, 2003. e-Pub 2003. PMID: 14661669.
46. Zhang J, Pedrosa I, Rofsky NM. MR techniques for renal imaging. Radiol Clin North Am 41(5):877-907, 2003. e-Pub 2003. PMID: 14521200.
47. Morrin MM, Pedrosa I, Rofsky NM. Magnetic resonance imaging for disorders of liver vasculature. Top Magn Reson Imaging 13(3):177-90, 2002. e-Pub 2002. PMID: 12357081.
48. Pedrosa I, Saiz A, Arrazola J, Ferreiros J, Pedrosa CS. Hydatid disease: radiologic and pathologic features and complications. Radiographics 20(3):795-817, 2000. e-Pub 2000. PMID: 10835129.

Other Articles

1. McGrath TA, Davenport MS, Silverman SG, Lim CS, Almalki YE, Arita Y, Bai X, Basha MAA, Dana J, Elbanna KY, Kamaya A, Jeyaraj SK, Park KJ, Park MY, Reinhold C, Tse JR, Wang H, Pedrosa I, Schieda N Bosniak Classification of Cystic Renal Masses Version 2019: Proportion of Malignancy by Class and Subclass-Systematic Review and Meta-Analysis. AJR Am J Roentgenol 224(3):e2432342, 2025. PMID: 39772585.
2. Pedrosa, I MRI Clear Cell Likelihood Score for Indeterminate Solid Renal Masses. Radiographics 43(7), 2023. PMID: 37319027.
3. Schieda N, Davenport MS, Silverman SG, Bagga B, Barkmeier D, Blank Z, Curci NE, Doshi AM, Downey RT, Edney E, Granader E, Gujrathi I, Hibbert RM, Hindman N, Walsh C, Ramsay T, Shinagare AB, Pedrosa I Multicenter Evaluation of Multiparametric MRI Clear Cell Likelihood Scores in Solid Indeterminate Small Renal Masses. Radiology 306(3):e239001, 2023. PMID: 36803006.
4. Sharma, A, Elias, R, Christie, A, Williams, NS, Pedrosa, I, Bjarnason, G, Brugarolas, J Erratum. Kidney Cancer 7(1):15, 2023. PMID: 36999139.
5. Schieda N, Davenport MS, Krishna S, Edney EA, Pedrosa I, Hindman N, Baroni RH, Curci NE, Shinagare A, Silverman SG Bosniak Classification of Cystic Renal Masses, Version 2019: A Pictorial Guide to Clinical Use. Radiographics 42(1):E33, 2022. PMID: 34990332.
6. Cai Q, Christie A, Rajaram S, Zhou Q, Araj E, Chintalapati S, Singla N, Cadeddu J, Margulis V, Pedrosa I, Rakheja D, McKay RM, Brugarolas J, Kapur P Corrigendum to ''Ontological analyses reveal clinically-significant clear cell renal cell carcinoma subtypes with convergent evolutionary trajectories into an aggressive type'' [EBioMedicine 51 (2020) 102526]. EBioMedicine 55:102707, 2020. PMID: 32339934.
7. Hu EM, Zhang A, Silverman SG, Pedrosa I, Wang ZJ, Smith AD, Chandarana H, Doshi A, Shinagare AB, Remer EM, Kaffenberger SD, Miller DC, Davenport MS Correction to: Multi-institutional analysis of CT and MRI reports evaluating indeterminate renal masses: comparison to a national survey investigating desired report elements. Abdom Radiol (NY) 43(11):3206, 2018. PMID: 29767283.

Editorials

1. Yuan Q, Pedrosa I. Editorial for "Luminal Water Imaging: Comparison With Diffusion-Weighted Imaging (DWI) and PI-RADS for Characterization of Prostate Cancer Aggressiveness". J Magn Reson Imaging 52(1):280-281, 2020. PMID: 32227379.

Letters to the Editor

1. Pusiol T, Piscioli I, Morini A, Pedrosa I, Rofsky NM. Discordance about the use of the term minimal fat angiomyolipoma. Radiology 267: 656-7, 2013.
2. Pedrosa I, Rofsky NM. Response. Radiology 267: 657, 2013.